These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 12235187

  • 1. Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.
    Borradaile NM, de Dreu LE, Barrett PH, Huff MW.
    J Lipid Res; 2002 Sep; 43(9):1544-54. PubMed ID: 12235187
    [Abstract] [Full Text] [Related]

  • 2. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
    Borradaile NM, de Dreu LE, Barrett PH, Behrsin CD, Huff MW.
    Biochemistry; 2003 Feb 11; 42(5):1283-91. PubMed ID: 12564931
    [Abstract] [Full Text] [Related]

  • 3. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP.
    Wilcox LJ, Borradaile NM, de Dreu LE, Huff MW.
    J Lipid Res; 2001 May 11; 42(5):725-34. PubMed ID: 11352979
    [Abstract] [Full Text] [Related]

  • 4. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin.
    Wilcox LJ, Barrett PH, Huff MW.
    J Lipid Res; 1999 Jun 11; 40(6):1078-89. PubMed ID: 10357840
    [Abstract] [Full Text] [Related]

  • 5. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor.
    Taghibiglou C, Van Iderstine SC, Kulinski A, Rudy D, Adeli K.
    Biochem Pharmacol; 2002 Feb 01; 63(3):349-60. PubMed ID: 11853686
    [Abstract] [Full Text] [Related]

  • 6. A two-site model for ApoB degradation in HepG2 cells.
    Wu X, Sakata N, Lele KM, Zhou M, Jiang H, Ginsberg HN.
    J Biol Chem; 1997 Apr 25; 272(17):11575-80. PubMed ID: 9111073
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Demonstration of a physical interaction between microsomal triglyceride transfer protein and apolipoprotein B during the assembly of ApoB-containing lipoproteins.
    Wu X, Zhou M, Huang LS, Wetterau J, Ginsberg HN.
    J Biol Chem; 1996 Apr 26; 271(17):10277-81. PubMed ID: 8626595
    [Abstract] [Full Text] [Related]

  • 11. Microsomal triacylglycerol transfer protein is required for lumenal accretion of triacylglycerol not associated with ApoB, as well as for ApoB lipidation.
    Kulinski A, Rustaeus S, Vance JE.
    J Biol Chem; 2002 Aug 30; 277(35):31516-25. PubMed ID: 12072432
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The microsomal triglyceride transfer protein facilitates assembly and secretion of apolipoprotein B-containing lipoproteins and decreases cotranslational degradation of apolipoprotein B in transfected COS-7 cells.
    Wang S, McLeod RS, Gordon DA, Yao Z.
    J Biol Chem; 1996 Jun 14; 271(24):14124-33. PubMed ID: 8662886
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of apolipoprotein B and triglyceride secretion in human hepatoma cells (HepG2).
    Haghpassand M, Wilder D, Moberly JB.
    J Lipid Res; 1996 Jul 14; 37(7):1468-80. PubMed ID: 8827519
    [Abstract] [Full Text] [Related]

  • 16. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge.
    Cianflone KM, Yasruel Z, Rodriguez MA, Vas D, Sniderman AD.
    J Lipid Res; 1990 Nov 14; 31(11):2045-55. PubMed ID: 1964953
    [Abstract] [Full Text] [Related]

  • 17. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
    Wilcox LJ, Barrett PH, Newton RS, Huff MW.
    Arterioscler Thromb Vasc Biol; 1999 Apr 14; 19(4):939-49. PubMed ID: 10195921
    [Abstract] [Full Text] [Related]

  • 18. Demonstration of biphasic effects of docosahexaenoic acid on apolipoprotein B secretion in HepG2 cells.
    Wu X, Shang A, Jiang H, Ginsberg HN.
    Arterioscler Thromb Vasc Biol; 1997 Nov 14; 17(11):3347-55. PubMed ID: 9409332
    [Abstract] [Full Text] [Related]

  • 19. Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells.
    Sakata N, Wu X, Dixon JL, Ginsberg HN.
    J Biol Chem; 1993 Nov 05; 268(31):22967-70. PubMed ID: 8226809
    [Abstract] [Full Text] [Related]

  • 20. Translocational status of ApoB in the presence of an inhibitor of microsomal triglyceride transfer protein.
    Macri J, Kazemian P, Kulinski A, Rudy D, Aiton A, Thibert RJ, Adeli K.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):1035-47. PubMed ID: 11027587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.